107 related articles for article (PubMed ID: 12864870)
1. End-stage renal disease and acute glomerulonephritis in Goajiro Indians.
Herrera J; Rodríguez-Iturbe B
Kidney Int Suppl; 2003 Feb; (83):S22-6. PubMed ID: 12864870
[TBL] [Abstract][Full Text] [Related]
2. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure.
Hoy WE; White AV; Tipiloura B; Singh GR; Sharma S; Bloomfield H; Swanson CE; Dowling A; McCredie DA
Nephrol Dial Transplant; 2016 Jun; 31(6):971-7. PubMed ID: 25061125
[TBL] [Abstract][Full Text] [Related]
3. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life.
Hoy WE; White AV; Dowling A; Sharma SK; Bloomfield H; Tipiloura BT; Swanson CE; Mathews JD; McCredie DA
Kidney Int; 2012 May; 81(10):1026-1032. PubMed ID: 22297679
[TBL] [Abstract][Full Text] [Related]
4. Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life.
White AV; Hoy WE; McCredie DA
Med J Aust; 2001 May; 174(10):492-6. PubMed ID: 11419767
[TBL] [Abstract][Full Text] [Related]
5. The multideterminant model of renal disease in a remote Australian Aboriginal population in the context of early life risk factors: lower birth weight, childhood post-streptococcal glomerulonephritis, and current body mass index influence levels of albuminuria in young Aboriginal adults.
Hoy WE; White AV; Tipiloura B; Singh G; Sharma SK; Bloomfield H; Swanson CE; Dowling A; McCredie DA
Clin Nephrol; 2015; 83(7 Suppl 1):75-81. PubMed ID: 25725247
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of tubular secretion of creatinine in health and in conditions associated with reduced nephron mass. Evidence for a tubular functional reserve.
Herrera J; Rodríguez-Iturbe B
Nephrol Dial Transplant; 1998 Mar; 13(3):623-9. PubMed ID: 9550637
[TBL] [Abstract][Full Text] [Related]
7. Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review.
Blyth CC; Robertson PW; Rosenberg AR
J Paediatr Child Health; 2007 Jun; 43(6):446-50. PubMed ID: 17535174
[TBL] [Abstract][Full Text] [Related]
8. Incidence of poststreptococcal glomerulonephritis in northwestern Ontario: Cross-sectional study at a tertiary care centre.
Thorgrimson J; Kwong JC; Dalcin D
Can Fam Physician; 2022 Jun; 68(6):e190-e195. PubMed ID: 35701209
[TBL] [Abstract][Full Text] [Related]
9. Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulonephritis.
Piyaphanee N; Ananboontarick C; Supavekin S; Sumboonnanonda A
Pediatr Int; 2017 Mar; 59(3):334-341. PubMed ID: 27542664
[TBL] [Abstract][Full Text] [Related]
10. [Association between race and incidence of end-stage renal disease secondary to glomerulonephritis: influence of the histologic type and presence of arterial hypertension].
Lopes AA; Silveira MA; Martinelli RP; Rocha H
Rev Assoc Med Bras (1992); 2001; 47(1):78-84. PubMed ID: 11340455
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma.
Karmarkar MG; Hule GP; Cameron A; Mehta PR; Khopkar U; Hase NK; Sriprakash KS
BMC Infect Dis; 2015 Mar; 15():113. PubMed ID: 25849124
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical presentation, pathological spectra, treatment and outcomes of biopsy-proven acute postinfectious glomerulonephritis in adult indigenous people of the Northern Territory of Australia.
Ramanathan G; Abeyaratne A; Sundaram M; Fernandes DK; Pawar B; Perry GJ; Sajiv C; Majoni SW
Nephrology (Carlton); 2017 May; 22(5):403-411. PubMed ID: 27062647
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity for Antibodies to DRS-G, a Virulence Factor from Streptococcus dysgalactiae subsp. equisimilis, Is an Independent Risk Factor for Poststreptococcus Glomerulonephritis and Chronic Kidney Disease in Mumbai, India.
Hule GP; Karmarkar MG; Cameron A; Hase N; Khopkar U; Mehta PR; McNeilly CL; McMillan D; Sriprakash KS
Clin Vaccine Immunol; 2015 Aug; 22(8):938-42. PubMed ID: 26084513
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Outcome of Post-Infectious Glomerulonephritis in Children in Southern India: A Prospective Study.
Gunasekaran K; Krishnamurthy S; Mahadevan S; Harish BN; Kumar AP
Indian J Pediatr; 2015 Oct; 82(10):896-903. PubMed ID: 25893528
[TBL] [Abstract][Full Text] [Related]
15. Poststreptococcal glomerulonephritis in children with congenital anomalies of the kidney and urinary tract.
Tasic V; Ristoska-Bojkovska N; Gucev Z; Lozanovski VJ
Ren Fail; 2015; 37(9):1440-3. PubMed ID: 26335537
[TBL] [Abstract][Full Text] [Related]
16. How bright is their future? Post-streptococcal glomerulonephritis in Indigenous communities in Australia.
Atkins RC
Med J Aust; 2001 May; 174(10):489-90. PubMed ID: 11419765
[No Abstract] [Full Text] [Related]
17. [Hypertension in patients with post-streptococcal glomerulonephritis].
Jovanović D; Bojanić N; Pantović R; Marić M; Skatarić V; Dimitrijević J
Vojnosanit Pregl; 1993; 50(4):343-8. PubMed ID: 8273303
[TBL] [Abstract][Full Text] [Related]
18. Renal functional reserve after acute poststreptococcal glomerulonephritis.
Cleper R; Davidovitz M; Halevi R; Eisenstein B
Pediatr Nephrol; 1997 Aug; 11(4):473-6. PubMed ID: 9260248
[TBL] [Abstract][Full Text] [Related]
19. [Influence of hypertension on the incidence of end-stage renal disease in negroes and mulattoes with glomerulonephritis].
Lopes AA; Silveira MA; Martinelli R; Noblat AC
Rev Assoc Med Bras (1992); 2002; 48(2):167-71. PubMed ID: 12205536
[TBL] [Abstract][Full Text] [Related]
20. Excessive burden of end-state renal disease among Canadian Indians: a national survey.
Young TK; Kaufert JM; McKenzie JK; Hawkins A; O'Neil J
Am J Public Health; 1989 Jun; 79(6):756-8. PubMed ID: 2786348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
